文献速递脊柱关节炎

强直性脊柱炎肾脏受累:基于TriNetX全球网络的回顾性人群队列研究

Renal involvement in ankylosing spondylitis: a retrospective, population-based cohort study using data from the TriNetX Global Network.
PubMed 文献 · RMD Open · 2026-04-13

该回顾性人群队列研究利用TriNetX全球协作网络,将成人强直性脊柱炎(AS)患者与倾向评分匹配的对照1:1比较。结果显示AS患者慢性肾病风险升高超过两倍(HR 2.51),透析启动风险最高(HR 7.58),急性肾损伤和肾小球疾病风险亦显著升高。结论支持在风湿病诊疗路径中常规进行肾脏监测。

要点

  • AS患者慢性肾病风险较匹配对照升高超过两倍(HR 2.51)。
  • 透析启动风险升高最为显著(HR 7.58),急性肾损伤和肾小球疾病风险亦翻倍。
  • 建议在风湿病诊疗路径中常规开展肾脏监测,以早期发现不可逆肾损伤。

核心结论

  • AS与肾脏疾病谱系风险显著升高相关,支持在风湿病诊疗路径中常规肾脏监测。

研究设计与样本

  • 回顾性人群队列研究,使用TriNetX全球协作网络匿名电子健康记录,成人AS患者与对照按倾向评分1:1匹配后采用Cox模型进行时间至事件分析。

主要发现

  • AS队列慢性肾病(主要结局)风险较匹配对照升高超过两倍(HR 2.51;95%CI 2.21至2.84)。
  • 次要结局中透析启动风险最高(HR 7.58;95%CI 6.19至9.27),其次为急性肾损伤(HR 2.18;95%CI 2.03至2.35)和肾小球疾病(HR 2.06;95%CI 1.71至2.49)。

临床怎么用

  • 在风湿病诊疗路径中对AS患者常规开展肾脏监测,以早期发现并减少不可逆肾损伤。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Renal involvement in ankylosing spondylitis (AS) is recognised but understudied, with heterogeneous reports ranging from urinalysis abnormalities to end-stage disease and malignancy. Robust, contemporary and population-level estimates remain lacking. OBJECTIVE: To quantify the burden and risk of major nephrological outcomes in AS versus matched controls, estimate long-term occurrence, and explore sex-specific differences. METHODS: We performed a retrospective, population-based cohort study using the TriNetX Global Collaborative Network of anonymised electronic health records. Adults with AS were compared 1:1 with controls using propensity score matching across demographic factors and relevant comorbidities. The primary renal outcome was chronic kidney disease (CKD), while the secondary outcomes were as follows: acute kidney injury (AKI), dialysis initiation, glomerular diseases, tubulointerstitial nephropathies, proteinuria, haematuria, urolithiasis, nephrological neoplasms and kidney transplantation. Time-to-event analyses used Cox models; robustness was assessed in prespecified sensitivity analyses. RESULTS: After matching, AS was associated with markedly higher hazards across the full spectrum of renal outcomes. The risk of developing CKD (primary outcome) was more than twofold higher in the AS cohort (HR 2.51; 95% CI 2.21 to 2.84). Among secondary outcomes, the highest risk was observed for dialysis initiation (HR 7.58; 95% CI 6.19 to 9.27), followed by AKI (HR 2.18; 95% CI 2.03 to 2.35) and glomerular diseases (HR 2.06; 95% CI 1.71 to 2.49). Associations were consistent across prespecified sensitivity analyses. CONCLUSIONS: AS confers a broad, multifactorial increase in renal morbidity. These findings support routine nephrological surveillance within rheumatology pathways. A multidisciplinary approach is warranted to enable earlier detection and mitigate irreversible kidney injury.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Tyczyńska KM, Krajewski PK, Świerkot J, et al. Renal involvement in ankylosing spondylitis: a retrospective, population-based cohort study using data from the TriNetX Global Network. RMD Open. 2026. PMID: 41974505. doi:10.1136/rmdopen-2025-006484

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。